| Title | Expert Opinion on Therapeutic Targets |
| Abbreviation | Expert Opin. Ther. Targets |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1) |
| h-index | 94 |
| Overall Rank/Ranking | 2235 |
| SCImago Journal Rank (SJR) | 1.444 |
| Impact Score | 5.54 |
| Publisher | Taylor and Francis Ltd. |
| Country | United Kingdom |
| ISSN | 14728222, 17447631 |
Expert Opinion on Therapeutic Targets ranks #40 of 216 in the Pharmacology & Pharmacy category in the 2008 ISI Journal Citation Reports.
Expert Opinion on Therapeutic Targets (ISSN 1472-8222 [print], 1744-7631 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on recently identified novel molecular drug targets, providing expert opinion on the scope for future development and impact on drug discovery.
Expert Opinion on Therapeutic Targets is a journal covering the technologies/fields/categories related to Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1). It is published by Taylor and Francis Ltd.. The overall rank of Expert Opinion on Therapeutic Targets is 2235. According to SCImago Journal Rank (SJR), this journal is ranked 1.444. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 94. The best quartile for this journal is Q1.
The ISSN of Expert Opinion on Therapeutic Targets journal is 14728222, 17447631. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Expert Opinion on Therapeutic Targets is cited by a total of 1759 articles during the last 3 years (Preceding 2021).
The impact score (IS) 2021 of Expert Opinion on Therapeutic Targets is 5.54, which is computed in 2022 as per its definition. Expert Opinion on Therapeutic Targets IS is increased by a factor of 0.27 and approximate percentage change is 5.12% when compared to preceding year 2020, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
IS 2021 of Expert Opinion on Therapeutic Targets is 5.54. If the same upward trend persists, impact score may rise in 2022 as well.
| Year | Impact Score (IS) |
|---|---|
| 2022/2023 | Coming Soon |
| 2021 | 5.54 |
| 2020 | 5.27 |
| 2019 | 4.58 |
| 2018 | 4.21 |
| 2017 | 4.21 |
| 2016 | 4.48 |
| 2015 | 4.45 |
| 2014 | 4.76 |
Expert Opinion on Therapeutic Targets has an h-index of 94. It means 94 articles of this journal have more than 94 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Expert Opinion on Therapeutic Targets is 14728222, 17447631. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Expert Opinion on Therapeutic Targets is 2235. According to SCImago Journal Rank (SJR), this journal is ranked 1.444. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Expert Opinion on Therapeutic Targets is published by Taylor and Francis Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1997-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Expert Opinion on Therapeutic Targets is Expert Opin. Ther. Targets. This abbreviation ('Expert Opin. Ther. Targets') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Oncology Letters | journal | 7682 | Spandidos Publications | 63 | 2.97 |
| Journal of Magnetics | journal | 19412 | The Korean Magnestics Society | 17 | 0.53 |
| East European Jewish Affairs | journal | 21965 | Taylor and Francis Ltd. | 9 | 0.10 |
| Rechtsmedizin | journal | 14826 | Springer Verlag | 22 | 0.88 |
| Linguistic Review | journal | 9857 | Walter de Gruyter GmbH | 36 | 0.66 |
| Acta Astronomica | journal | 6477 | Copernicus Foundation for Polish Astronomy | 64 | 1.69 |
| Bulletin of the American Society of Papyrologists | journal | 25862 | American Society of Papyrologists | 9 | 0.00 |
| Cedille | journal | 23919 | Asociacion de Profesores de Frances de la Universidad Espanola | 3 | 0.07 |
| New Theatre Quarterly | journal | 24447 | Cambridge University Press | 14 | 0.16 |
| Journal of Pharmacy and Bioallied Sciences | journal | 15675 | Wolters Kluwer Medknow Publications | 42 | 1.26 |
| Year | Impact Score (IS) |
|---|---|
| 2022/2023 | Coming Soon |
| 2021 | 5.54 |
| 2020 | 5.27 |
| 2019 | 4.58 |
| 2018 | 4.21 |
| 2017 | 4.21 |
| 2016 | 4.48 |
| 2015 | 4.45 |
| 2014 | 4.76 |
5.54
94
2235
1.444
